Registry of Lobbyists

Registration - In-house Corporation

Baxter Corporation / Stephen Thompson, President & General Manager

Registration Information

In-house Corporation name: Baxter Corporation
Responsible Officer Name: Stephen Thompson, President & General Manager 
Responsible Officer Change History
Initial registration start date: 2007-01-31
Registration status: Inactive
Registration Number: 930614-14650

Associated Communications

Total Number of Communication Reports: 17

Monthly communication reports in the last 6 months: 0

Version 1 of 22 (2007-01-31 to 2007-08-03)

Version 1 of 22 (2007-01-31 to 2007-08-03) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Responsible Officer and Corporation

Corporation: Baxter Corporation
4 Robert Speck Parkway, Ste. 700
Mississauga, ON  L4Z 3Y4
Canada
Telephone number: 905-281-6828
Fax number: 905-281-6570  
Responsible officer name and position during the period of this registration: Barbara Leavitt, President  
Description of activities: Baxter Corporation is the Canadian subsidiary of Baxter International, a global health care company. Baxter's BioScience, Medication Delivery and Renal products and services are used to treat Canadians with such medical conditions as cancer, hemophilia, immune deficiencies, infectious diseases, kidney disease and trauma.
 
The client is a subsidiary of the following parent companies: Baxter International
One Baxter Parkway
Deerfield, IL
United States of America 60015-4625

Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Corporation

Name: Nancy Abbey
Position title: Director, Government Relations & Health Strategy
Public offices held: No
 
Name: Lisa Armour
Position title: Director, Regulatory Affairs
Public offices held: No
 
Name: Pam Bobbette
Position title: VP, Quality Assurance
Public offices held: No
 
Name: Michael Hamilton
Position title: VP, Health Systems and Channel Mgmt
Public offices held: No
 
Name: Barb Leavitt
Position title: President
Public offices held: No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Health Canada (HC), National Defence (DND)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Consumer Issues, Defence, Government Procurement, Health, Industry, Science and Technology
 
Subject Matter: Retrospective: Medical equipment funding; pandemic border issues;
Subject Matter: Prospective: Pandemic border issues; regulatory approval times; gmp revisions
 

Details Regarding the Identified Subject Matter

Categories Description
Regulation Good Manufacturing Practices (GMP) 2007 Proposed Guidelines




Date Modified: